vs
Side-by-side financial comparison of DARLING INGREDIENTS INC. (DAR) and Option Care Health, Inc. (OPCH). Click either name above to swap in a different company.
DARLING INGREDIENTS INC. is the larger business by last-quarter revenue ($1.6B vs $1.4B, roughly 1.1× Option Care Health, Inc.). Option Care Health, Inc. runs the higher net margin — 3.6% vs 1.2%, a 2.4% gap on every dollar of revenue. On growth, Option Care Health, Inc. posted the faster year-over-year revenue change (12.2% vs 10.0%). Over the past eight quarters, Option Care Health, Inc.'s revenue compounded faster (13.0% CAGR vs -1.6%).
Darling Ingredients Inc. is a global sustainable natural ingredients maker that converts edible and inedible organic byproducts into high-value products: food-grade nutritional ingredients, animal feed additives, pharmaceutical raw materials and biofuel components, serving food, agriculture, pharma and renewable energy markets across North America, Europe and Asia-Pacific.
GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...
DAR vs OPCH — Head-to-Head
Income Statement — Q3 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.6B | $1.4B |
| Net Profit | $19.4M | $51.8M |
| Gross Margin | 24.7% | 19.0% |
| Operating Margin | 4.6% | 5.9% |
| Net Margin | 1.2% | 3.6% |
| Revenue YoY | 10.0% | 12.2% |
| Net Profit YoY | 14.2% | -3.8% |
| EPS (diluted) | $0.12 | $0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $1.6B | $1.4B | ||
| Q2 25 | $1.5B | $1.4B | ||
| Q1 25 | $1.4B | $1.3B | ||
| Q4 24 | $1.4B | $1.3B | ||
| Q3 24 | $1.4B | $1.3B | ||
| Q2 24 | $1.5B | $1.2B | ||
| Q1 24 | $1.4B | $1.1B | ||
| Q4 23 | $1.6B | $1.1B |
| Q3 25 | $19.4M | $51.8M | ||
| Q2 25 | $12.7M | $50.5M | ||
| Q1 25 | $-26.2M | $46.7M | ||
| Q4 24 | $101.9M | $60.1M | ||
| Q3 24 | $16.9M | $53.9M | ||
| Q2 24 | $78.9M | $53.0M | ||
| Q1 24 | $81.2M | $44.8M | ||
| Q4 23 | $84.5M | — |
| Q3 25 | 24.7% | 19.0% | ||
| Q2 25 | 23.3% | 19.0% | ||
| Q1 25 | 22.6% | 19.7% | ||
| Q4 24 | 23.5% | 21.3% | ||
| Q3 24 | 22.1% | 20.1% | ||
| Q2 24 | 22.5% | 20.3% | ||
| Q1 24 | 21.4% | 20.8% | ||
| Q4 23 | 27.0% | 22.0% |
| Q3 25 | 4.6% | 5.9% | ||
| Q2 25 | 5.1% | 5.8% | ||
| Q1 25 | 2.1% | 5.9% | ||
| Q4 24 | 8.6% | 6.9% | ||
| Q3 24 | 4.2% | 6.7% | ||
| Q2 24 | 10.2% | 6.6% | ||
| Q1 24 | 9.7% | 6.0% | ||
| Q4 23 | 9.8% | 7.5% |
| Q3 25 | 1.2% | 3.6% | ||
| Q2 25 | 0.9% | 3.6% | ||
| Q1 25 | -1.9% | 3.5% | ||
| Q4 24 | 7.2% | 4.8% | ||
| Q3 24 | 1.2% | 4.2% | ||
| Q2 24 | 5.4% | 4.3% | ||
| Q1 24 | 5.7% | 3.9% | ||
| Q4 23 | 5.2% | — |
| Q3 25 | $0.12 | $0.32 | ||
| Q2 25 | $0.08 | $0.31 | ||
| Q1 25 | $-0.16 | $0.28 | ||
| Q4 24 | $0.63 | $0.36 | ||
| Q3 24 | $0.11 | $0.31 | ||
| Q2 24 | $0.49 | $0.30 | ||
| Q1 24 | $0.50 | $0.26 | ||
| Q4 23 | $0.53 | $0.33 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $91.5M | $309.8M |
| Total DebtLower is stronger | $4.0B | $1.2B |
| Stockholders' EquityBook value | $4.7B | $1.4B |
| Total Assets | $10.5B | $3.5B |
| Debt / EquityLower = less leverage | 0.86× | 0.86× |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $91.5M | $309.8M | ||
| Q2 25 | $94.6M | $198.8M | ||
| Q1 25 | $81.5M | $171.4M | ||
| Q4 24 | $76.0M | $412.6M | ||
| Q3 24 | $114.8M | $483.0M | ||
| Q2 24 | $121.6M | $376.9M | ||
| Q1 24 | $145.5M | $219.5M | ||
| Q4 23 | $126.5M | $343.8M |
| Q3 25 | $4.0B | $1.2B | ||
| Q2 25 | $3.9B | $1.1B | ||
| Q1 25 | $3.8B | $1.1B | ||
| Q4 24 | $3.9B | $1.1B | ||
| Q3 24 | $4.1B | $1.1B | ||
| Q2 24 | $4.3B | $1.1B | ||
| Q1 24 | $4.4B | $1.1B | ||
| Q4 23 | $4.4B | $1.1B |
| Q3 25 | $4.7B | $1.4B | ||
| Q2 25 | $4.6B | $1.4B | ||
| Q1 25 | $4.4B | $1.4B | ||
| Q4 24 | $4.4B | $1.4B | ||
| Q3 24 | $4.6B | $1.4B | ||
| Q2 24 | $4.5B | $1.4B | ||
| Q1 24 | $4.6B | $1.4B | ||
| Q4 23 | $4.6B | $1.4B |
| Q3 25 | $10.5B | $3.5B | ||
| Q2 25 | $10.3B | $3.4B | ||
| Q1 25 | $10.0B | $3.3B | ||
| Q4 24 | $10.1B | $3.4B | ||
| Q3 24 | $10.6B | $3.4B | ||
| Q2 24 | $10.6B | $3.3B | ||
| Q1 24 | $10.9B | $3.2B | ||
| Q4 23 | $11.1B | $3.2B |
| Q3 25 | 0.86× | 0.86× | ||
| Q2 25 | 0.85× | 0.82× | ||
| Q1 25 | 0.86× | 0.82× | ||
| Q4 24 | 0.89× | 0.79× | ||
| Q3 24 | 0.91× | 0.78× | ||
| Q2 24 | 0.97× | 0.79× | ||
| Q1 24 | 0.95× | 0.74× | ||
| Q4 23 | 0.95× | 0.75× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $224.3M | $139.4M |
| Free Cash FlowOCF − Capex | — | $130.2M |
| FCF MarginFCF / Revenue | — | 9.1% |
| Capex IntensityCapex / Revenue | — | 0.6% |
| Cash ConversionOCF / Net Profit | 11.59× | 2.69× |
| TTM Free Cash FlowTrailing 4 quarters | — | $220.7M |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $224.3M | $139.4M | ||
| Q2 25 | $145.8M | $90.3M | ||
| Q1 25 | $249.0M | $-7.2M | ||
| Q4 24 | $154.4M | $36.1M | ||
| Q3 24 | $274.5M | $160.4M | ||
| Q2 24 | $146.5M | $195.7M | ||
| Q1 24 | $263.9M | $-68.8M | ||
| Q4 23 | $217.0M | $51.0M |
| Q3 25 | — | $130.2M | ||
| Q2 25 | — | $81.2M | ||
| Q1 25 | — | $-16.6M | ||
| Q4 24 | — | $25.8M | ||
| Q3 24 | — | $150.7M | ||
| Q2 24 | — | $185.9M | ||
| Q1 24 | — | $-74.6M | ||
| Q4 23 | — | $31.1M |
| Q3 25 | — | 9.1% | ||
| Q2 25 | — | 5.7% | ||
| Q1 25 | — | -1.2% | ||
| Q4 24 | — | 2.0% | ||
| Q3 24 | — | 11.8% | ||
| Q2 24 | — | 15.1% | ||
| Q1 24 | — | -6.5% | ||
| Q4 23 | — | 2.8% |
| Q3 25 | — | 0.6% | ||
| Q2 25 | — | 0.6% | ||
| Q1 25 | — | 0.7% | ||
| Q4 24 | — | 0.8% | ||
| Q3 24 | — | 0.8% | ||
| Q2 24 | — | 0.8% | ||
| Q1 24 | — | 0.5% | ||
| Q4 23 | — | 1.8% |
| Q3 25 | 11.59× | 2.69× | ||
| Q2 25 | 11.52× | 1.79× | ||
| Q1 25 | — | -0.15× | ||
| Q4 24 | 1.52× | 0.60× | ||
| Q3 24 | 16.19× | 2.98× | ||
| Q2 24 | 1.86× | 3.69× | ||
| Q1 24 | 3.25× | -1.54× | ||
| Q4 23 | 2.57× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DAR
| Fats | $428.4M | 27% |
| Food Ingredients | $380.6M | 24% |
| Diamond Green Diesel Holdings Llc Joint Venture | $342.1M | 22% |
| Fuel Ingredients | $154.3M | 10% |
| Used Cooking Oil | $125.9M | 8% |
| Other Rendering | $76.9M | 5% |
| Bakery | $46.9M | 3% |
| Other Products And Services | $12.2M | 1% |
OPCH
| Commercial Customer | $1.3B | 87% |
| Government Customer | $172.8M | 12% |
| Patient Customer | $10.1M | 1% |
| Corporate Joint Venture | $1.9M | 0% |
